Friday 9 December 2016

Therapeutic vaccine promising for leukemia

New research arising from the Cancer Vaccine Program at the Beth Israel Deaconness Medical Center in Boston  indicates that an anti-cancer vaccine derived from an acute myeloid leukemia patient's cells significantly increases the chance of long-term survival.

According to senior researcher Dr. David Avigan, "the vaccine has produced long-term remission for 70% of a small group of vaccinated patients with an average age of 63."

To read more about this study, click here.

No comments:

Post a Comment